Hospira Company Profile

✉ Email this page to a colleague

HOSPIRA has five hundred and eighteen approved drugs.

There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.

There are seventy patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and twenty supplementary protection certificates in sixteen countries.

International Patents:	70
US Patents:	9
Tradenames:	333
Ingredients:	210
NDAs:	518
Patent Litigation for Hospira:	See patent lawsuits for Hospira
PTAB Cases with Hospira as petitioner:	See PTAB cases with Hospira as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	089635-001	Jun 21, 1988	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira	LORAZEPAM	lorazepam	INJECTABLE;INJECTION	074243-002	Apr 12, 1994	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Hospira	LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%	lidocaine hydrochloride	INJECTABLE;SPINAL	083914-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Hospira	CALCITRIOL	calcitriol	INJECTABLE;INJECTION	075816-002	Jan 16, 2004		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Hospira	BRETYLOL	bretylium tosylate	INJECTABLE;INJECTION	017954-001	Approved Prior to Jan 1, 1982	RE29618	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-003	Mar 13, 2013	6,716,867*PED	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-001	Dec 17, 1999	6,716,867*PED	⤷ Try a Trial
Hospira	PRECEDEX	dexmedetomidine hydrochloride	INJECTABLE;INJECTION	021038-002	Mar 13, 2013	4,910,214*PED	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	100 mcg/mL	➤ Subscribe	2009-04-08
➤ Subscribe	Injection	4 mcg/mL, 20 mL vials	➤ Subscribe	2015-09-30
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	4 mcg/mL, 50 mL and 100 mL vials	➤ Subscribe	2013-12-26

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2957286	CR 2018 00043	Denmark	⤷ Try a Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179/001-009 20170721
2377536	2013/024	Ireland	⤷ Try a Trial	PRODUCT NAME: 4-AMINOPYRIDINE (FAMPRIDINE) OR A SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/11/699/001-EU/1/22/699-002 20110720
1586316	SPC/GB11/054	United Kingdom	⤷ Try a Trial	PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523
0489070	SPC/GB04/035	United Kingdom	⤷ Try a Trial	PRODUCT NAME: H-(D-PHE)-PRO-ARG-PRO-(GLY)4-ASN-GLY-ASP-PHE-GLU-GLU-ILE-PRO-GLU-GLU-TYR-LEU-OH, OPTIONALLY IN THE FORM OF ITS PHARMACEUTICALLY ACCEPTABLE SALT (BIVALIRUDIN); REGISTERED: UK EU/1/04/289/001 20040920
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.